PeriOperative ISchemic Evaluation-2 Trial
NCT01082874 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 10010
Last updated 2016-08-25
Summary
Major surgeries not involving the heart are common, and major heart problems during or after such surgeries represent a large population health problem. Few treatments to prevent heart problems around the time of surgery have been tested. There is encouraging data suggesting that small doses of Acetyl-Salicylic Acid (ASA) and Clonidine, which are two medications, given individually for a short period before and after major surgeries may prevent major heart problems. The POISE-2 Trial is a large international study to test if ASA and Clonidine can prevent heart attacks and deaths from heart problems around the time of surgery.
Conditions
Interventions
- DRUG
-
Active Clonidine
Pre-op (goal 2-4 hours): 2 x 0.1mg oral tablets and transdermal patch (0.2 mg/day). Patch to be removed 72 hours post-op.
- DRUG
-
Placebo Clonidine
Pre-op (goal 2-4 hours): 2 oral placebo tablets and transdermal placebo patch. Patch to be removed 72 hours post-op.
- DRUG
-
Active ASA
Pre-op (goal 2-4 hours): 2 x 100mg oral tablets. Post-op: patients ingest one tablet a day (100 mg ASA) for 7 days if patient was were taking ASA chronically prior to surgery or for 30 days if they were not chronically taking ASA prior to surgery
- DRUG
-
Placebo ASA
Pre-op (goal 2-4 hours): 2 oral placebo tablets. Post-op: patients ingest one placebo tablet a day for 7 days if patient was were taking ASA chronically prior to surgery or for 30 days if they were not chronically taking ASA prior to surgery
Sponsors & Collaborators
- collaborator OTHER
-
Hamilton Health Sciences Corporation
lead OTHER
Principal Investigators
-
P.J. Devereaux, MD, PhD · Population Health Research Institute
-
Salim Yusuf, DPhil · Population Health Research Institute
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- QUADRUPLE
- Model
- FACTORIAL
Eligibility
- Min Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-07-31
- Primary Completion
- 2014-03-31
- Completion
- 2015-01-31
Countries
- United States
- Argentina
- Australia
- Austria
- Belgium
- Brazil
- Canada
- Chile
- Colombia
- Denmark
- France
- Germany
- Hong Kong
- India
- Italy
- Malaysia
- New Zealand
- Pakistan
- Peru
- South Africa
- Spain
- Switzerland
- United Kingdom
Study Locations
More Related Trials
-
Aspirin in Reduction of Tension II Study
NCT01379079 ·Status: COMPLETED ·Phase: PHASE4
-
Perioperative Antiplatelet Therapy in Patients With Drug-eluting Stent Undergoing Noncardiac Surgery
NCT02797548 ·Status: COMPLETED ·Phase: PHASE4
-
Aspirin Withdrawal in Non-ischaemic Cardiomyopathy Study
NCT01534026 ·Status: COMPLETED ·Phase: PHASE4
-
Use Of SB424323 With Aspirin In Non-Valvular Atrial Fibrillation In Patients At A Low Or Intermediate Risk For Stroke
NCT00240643 ·Status: COMPLETED ·Phase: PHASE2
-
Multiple Daily Doses of Aspirin to Overcome Hyporesponsiveness Post Cardiac Bypass Surgery (ASACABG)- Part B
NCT01902498 ·Status: COMPLETED ·Phase: PHASE2
-
Secondary Prevention of Cardiovascular Disease in the Elderly Trial
NCT02596126 ·Status: COMPLETED ·Phase: PHASE3
-
Association Between Low Dose Acetylsalicylic Acid (ASA) and Proton Pump Inhibitors and Risk of Acute Myocardial Infarction or Coronary Death
NCT01360047 ·Status: COMPLETED
-
A Study of Aspirin and Clopidogrel in Patients With Idiopathic Pulmonary Arterial Hypertension
NCT00105209 ·Status: COMPLETED ·Phase: PHASE2
-
PPARGC1β and CNTN4 Genotype Aspirin Study
NCT02970604 ·Status: UNKNOWN ·Phase: PHASE4
-
Association of PeriOPerative Aspirin-ResisTance and CardioVascular Outcome
NCT04053894 ·Status: UNKNOWN
-
Anti-platelet Therapy in the Prevention of Cardiovascular Disease in Patients With COPD (APPLE-COPD: ICON 2)
NCT03487406 ·Status: COMPLETED ·Phase: PHASE2
-
STAT-STatin and Aspirin in Trauma
NCT02901067 ·Status: TERMINATED ·Phase: PHASE2
-
Heart Outcomes Prevention Evaluation-3
NCT00468923 ·Status: COMPLETED ·Phase: PHASE4
-
Perioperative Aspirin Usage Survey
NCT02561507 ·Status: TERMINATED
-
Coronary Artery Ectasia, Efficacy of Various Anti Thrombotic Regimens.
NCT05718531 ·Status: UNKNOWN ·Phase: PHASE3
-
Prospective Double-blind Study for the Use of Aspirin During Transurethral Surgery of the Bladder or the Prostate
NCT00861367 ·Status: WITHDRAWN ·Phase: NA
-
Aspirin Continuation or Interruption in Patients at Moderate Risk for Cardiovascular Events Undergoing Colonoscopy and/or Polypectomy
NCT07052799 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy and Safety of Aspirin and Clopidogrel in the Atrial Fibrillation With Low or Moderate Stroke Risk
NCT02960126 ·Status: UNKNOWN ·Phase: PHASE3
-
Low-dose Acetylsalicylic Acid Before Non-cardiac Surgery
NCT03049566 ·Status: COMPLETED
-
Perioperative Aspirin Response in Patients Undergoing Vascular Surgery
NCT03587324 ·Status: COMPLETED ·Phase: NA
-
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
NCT03968393 ·Status: RECRUITING ·Phase: PHASE4
-
Personalizing Aspirin Therapy in Peripheral Arterial Disease Patients
NCT04269863 ·Status: UNKNOWN ·Phase: NA
-
Does Early Re-administration of Aspirin/Clopidogrel Increase the Risk of Bleeding From Artificial Ulcer After EMR or ESD?
NCT01621451 ·Status: UNKNOWN ·Phase: PHASE4
-
Synergy Between Stent and Drugs to Avoid Ischemic Recurrences After Percutaneous Coronary Intervention
NCT00611286 ·Status: COMPLETED ·Phase: PHASE4
-
The Effects of Physical Training, ASA (Aspirin), and Clopidogrel on the Walking Capacity of Patients With Stage II Peripheral Arterial Disease (PAD)
NCT00189618 ·Status: COMPLETED ·Phase: PHASE4